Mass Spectrometry Market Size, Share, Trends and Revenue by 2030

Mass Spectrometry Market Sizing -

The SNS Insider report indicates that the Mass Spectrometry Market was valued at USD 5195.45 million in 2022, and is expected to reach Mass Spectrometry Market size of USD 9723.78 million by 2030, with a compound annual growth rate (CAGR) of 8.15% expected over the forecast period from 2023 to 2030.

Mass Spectrometry Market Report Scope -

The Mass Spectrometry Market for mass spectrometry is expected to grow strongly over the forecast period. Mass spectrometry, a key analytical tool in the pharmaceutical and health care industries, has risen to prominence. For the separation of complex biological mixtures such as peptides derived, advanced methods including ion mobility spectrometry and capillary electrophoresis are applied. Mass Spectrometry Market growth is expected to be driven by increasing use of mass spectrometry in proteomics, metabolomics and the pharmaceutical sector as well as miniaturisation trends.

In the latest findings from SNS Insider's research, the HUPO Proteomics Standards Initiative has introduced alluring guidelines for cutting-edge data-independent acquisition (DIA) workflows and the integration of the Universal Spectrum Identifier system. These guidelines are designed not only to streamline mass spectrometry workflows but also to captivate attention by ensuring a reduction in false-positive protein identifications and the attainment of a notably high level of accuracy.

Get a Free Sample of this Report @ https://www.snsinsider.com/sample-request/3835

Key Players Included are -

• Thermo Fisher Scientific, Inc
• Agilent Technologies, Inc
• Danaher Corporation
• Waters Corporation
• Bruker Corporation
• Shimadzu Corporation
• PerkinElmer, Inc
• Rigaku Corporation
• LECO Corporation
• JEOL Ltd
• SCIEX, and Others

Mass Spectrometry Market Opportunities -

Emerging Mass Spectrometry Markets will provide a number of opportunities in the Forecast Period
The growing number of emerging Mass Spectrometry Markets will benefit from the expansion of the Mass Spectrometry Market. In developing countries such as India and China, the Mass Spectrometry Market for Mass Spectrometry offers many opportunities to expand. In India and China, due to greenfield projects in various end user sectors, the demand for hybrid spectrometry and single wavelength spectrometer equipment is high.

Segmentation Analysis in Mass Spectrometry Market -

→ In 2022, based on product, the instrument segment accounted for the highest revenue share of 77.39%. Spectrometers offer a wide range of applications in the biotechnology industry, which is seeing increasing awareness about the advantages of mass spectrometry procedures. In clinical and preclinical trials for the discovery of drugs and in biomedical research in the pharmaceutical industry, these instruments may be used.

→ In 2022, based on end use, the pharmaceutical and biotechnology sector accounted for a Mass Spectrometry Market share of 43.98%, driven by extensive use of protein sequencing using mass spectrometry within the pharmaceutical industry to discover and develop medicines. This segment is expected to continue driving Mass Spectrometry Market growth due to growing demand for biomolecule analysis and drug component analysis. Also, by increased investments in Biopharmaceutical Research and growing R&D prospects for Proteins.

Key Market SEgmentation -

By Product
• Instruments
• Consumables & Services

By Technology
• Quadrupole Liquid Chromatography-Mass Spectrometry
• Gas Chromatography-Mass Spectrometry (GC-MS)
• Fourier Transform-Mass Spectrometry (FT-MS)
• Time-of-Flight Mass Spectrometry (TOFMS)
• Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight
Mass Spectrometry (MALDI-TOF)
• Magnetic Sector Mass Spectrometry
• Others

By Application
• Proteomics
• Metabolomics
• Glycomics
• Others

By End User
• Government & Academic Institutions
• Pharmaceutical & Biotechnology Companies
• Others

In 2022, the pharmaceutical & biotechnology companies segment is expected to dominate the market growth of 44.0% during the forecast period owing to the increasing use of protein sequencing in the pharmaceutical industry for drug discovery and development processes.

Key Regional Development -

North America accounted for the largest Mass Spectrometry Market share of 41.94% in 2022, due to the high level of R&D activity and the presence of an established research and healthcare infrastructure. Similarly, the increased focus on disease prevention measures in this area also contributes to demand for mass spectrometry. In addition, there is a significant amount of government funding in the region and Mass Spectrometry Market growth could be supported by it.
Asia Pacific is expected to grow at an accelerated compound annual growth rate of 8.97% during the forecast period, due to the availability of a large population and increasing focus on health systems. The Asia Pacific Mass Spectrometry Market for protein therapeutics has also presented substantial growth opportunities, due to the increased focus on research into Proteomics and Genomics as well as an increase in initiatives taken by academic institutions with a view to developing proteins.

Make Enquiry to get detailed information about this Report @ https://www.snsinsider.com/enquiry/3835

Key Takeaway from Mass Spectrometry Market Study -

Based on the product segmentation, in view of growing demand from different end use industries and adoption of new technologies which require special instruments, the Instruments segment is expected to lead the Mass Spectrometry Market over the forecast period with a significant Mass Spectrometry Market share.

In terms of the region, in 2022 North America accounted for a significant Mass Spectrometry Market share and is likely to remain an attractive Mass Spectrometry Market over the coming years. This Mass Spectrometry Market expansion is supported by factors such as technological progress, substantial investment in healthcare R&D and the presence of large industry players in the region.

Recent Development Related to Mass Spectrometry Market -

→ In June 2023, The Thermo Scientific TM, Orbitrap TM, Astral TM mass spectrometer was introduced by Thermo Fisher Scientific, Inc. The Astral analyzer enables researchers to effectively identify proteins, leading to ground-breaking discoveries for clinical biomarkers, diseases, and therapies.

→ In June 2023, Agilent Technologies, Inc. has introduced Inspirational LCTQ and LCQTOF Mass Spectrometry Solutions. The Agilent 6495 Triple Quadrupole LC/MS is an ideal choice for targeted analysis, offering high sensitivity, and the Agilent Revident Quadrupole Time-of-Flight LC/MS (LC/QTOF) System is an intelligent instrument architecture for efficient operation and productivity.

Secure Exclusive access to this comprehensive report @ https://www.snsinsider.com/checkout/3835

Table of Contents - Major Key Points

1.Introduction
2.Research Methodology
3.Market Dynamics
4.Impact Analysis
4.1COVID-19 Impact Analysis
4.2Impact of Ukraine- Russia war
4.3Impact of ongoing Recession
5.Value Chain Analysis
6.Porter's 5 Forces Model
7.PEST Analysis
8.Mass Spectrometry Market Segmentation, by Product
9.Mass Spectrometry Market Segmentation, by Technology
10.Mass Spectrometry Market Segmentation, by Application
11.Mass Spectrometry Market Segmentation, by End User
12.Regional Analysis
13.Company Profiles
14.Competitive Landscape
15.Conclusion

Akash Anand - Head of Business Development & Strategy,
Info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com/
Read our  other Healthcare Related Report

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

This release was published on openPR.